Clinical Trial Update: Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial investigates the effects of COX-2 and EGFR suppression on molecular markers of angiogenesis and proliferation in oral cavity squamous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Buccal Mucosa
• Head and Neck Cancers
• Oral Squamous Cell Carcinoma
• Tongue Cancers

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Oral Squamous Cell Carcinoma, Carcinoma of Buccal Mucosa | Phase 2 | Status: UNKNOWN